Cci clinical trials

Explore recruiting cci clinical trials.

Also recruiting in Europe

Cci trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of ABO-101 in Participants with Primary Hyperoxaluria Type 1 (PH1)

Germany, France, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults

Croatia, Poland, Germany, Czechia, Slovakia, Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

Efficacy and safety of NNC0487-0111 compared to placebo on morbidity and mortality in people with heart failure with preserved or mildly reduced ejection fraction and obesity (HF-POLARIS).

Denmark, Greece, Bulgaria, Italy, Netherlands, Spain +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ARTEMIS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction.

Greece, Bulgaria, Germany, Poland, Netherlands, Italy +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Protocol Title: Efficacy and safety of once-weekly subcutaneous NNC0662-0419 in participants with type 2 diabetes – a dose-finding study

Spain, Hungary, Portugal, Poland, Slovakia, Croatia

Therapeutic exploratory (Phase II) EU CTIS Study details

Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health

Denmark